BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 32441450)

  • 1. Treatment patterns and outcomes in adolescents and young adults with Hodgkin lymphoma in pediatric versus adult centers: An IMPACT Cohort Study.
    Gupta S; Baxter NN; Hodgson D; Punnett A; Sutradhar R; Pole JD; Nagamuthu C; Lau C; Nathan PC
    Cancer Med; 2020 Oct; 9(19):6933-6945. PubMed ID: 32441450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study.
    Gupta S; Pole JD; Baxter NN; Sutradhar R; Lau C; Nagamuthu C; Nathan PC
    Cancer Med; 2019 May; 8(5):2095-2103. PubMed ID: 30912628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
    Zawati I; Adouni O; Finetti P; Manai M; Manai M; Gamoudi A; Birnbaum D; Bertucci F; Mezlini A
    Cancer Radiother; 2020 Jun; 24(3):206-214. PubMed ID: 32171674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adolescents and young adult acute myeloid leukemia outcomes at pediatric versus adult centers: A population-based study.
    Gupta S; Baxter NN; Sutradhar R; Pole JD; Nagamuthu C; Lau C; Nathan PC
    Pediatr Blood Cancer; 2021 Aug; 68(8):e28939. PubMed ID: 33559361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of locus of care on outcomes in adolescents and young adults with osteosarcoma and Ewing sarcoma treated at pediatric versus adult cancer centers: An IMPACT cohort study.
    Mortazavi M; Baxter NN; Gupta S; Gupta AA; Lau C; Nagamuthu C; Nathan PC
    Pediatr Blood Cancer; 2022 Apr; 69(4):e29458. PubMed ID: 35029312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of adolescents and young adults compared to children with Hodgkin lymphoma treated with response-based chemotherapy on pediatric protocols: A Children's Oncology Group report.
    Fernández KS; Schwartz CL; Chen L; Constine LS; Chauvenet A; de Alarcón PA
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28612375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior outcomes with paediatric protocols in adolescents and young adults with aggressive B-cell non-Hodgkin lymphoma.
    Gupta S; Alexander S; Pole JD; Sutradhar R; Crump M; Nagamuthu C; Baxter NN; Nathan PC
    Br J Haematol; 2022 Feb; 196(3):743-752. PubMed ID: 34599525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Involved-Field Radiation Therapy Protocol Deviations in Pediatric Versus Adolescent and Young Adults With Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD0031.
    Parzuchowski A; Bush R; Pei Q; Friedman DL; FitzGerald TJ; Wolden SL; Dharmarajan KV; Constine LS; Laurie F; Kessel SK; Appel B; Fernandez K; Punnett A; Schwartz CL; Cox J; Terezakis SA
    Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1119-1125. PubMed ID: 29722656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hodgkin's lymphoma in adolescents: where to treat it--in an adult or pediatric institution?].
    Müller J; Molnár Z; Illés A; Csóka M; Jakab Z; Deák B; Schneider T; Várady E; Rosta A; Simon Z; Keresztes K; Gergely L; Kovács G
    Orv Hetil; 2008 Nov; 149(47):2221-7. PubMed ID: 19004744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABVD chemotherapy with reduced radiation therapy rates in children, adolescents and young adults with all stages of Hodgkin lymphoma.
    Marr KC; Connors JM; Savage KJ; Goddard KJ; Deyell RJ
    Ann Oncol; 2017 Apr; 28(4):849-854. PubMed ID: 28327925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes in intermediate-risk pediatric lymphocyte-predominant Hodgkin lymphoma: A report from the Children's Oncology Group.
    Marks LJ; Pei Q; Bush R; Buxton A; Appel B; Kelly KM; Schwartz CL; Friedman DL
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27375. PubMed ID: 30277639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment patterns and outcomes in adolescents and young adults with nodular lymphocyte-predominant Hodgkin lymphoma: an IMPACT cohort study.
    Punnett A; Baxter NN; Hodgson D; Sutradhar R; Pole JD; Lau C; Nathan PC; Gupta S
    Br J Haematol; 2023 Jun; 201(6):1081-1087. PubMed ID: 37015867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil.
    Hsu SC; Metzger ML; Hudson MM; Pedrosa F; Lins M; Pedrosa M; Barros C; Maciel K; Pui CH; Ribeiro RC; Howard SC
    Pediatr Blood Cancer; 2007 Aug; 49(2):139-44. PubMed ID: 16642484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin's lymphoma in adolescents.
    Foltz LM; Song KW; Connors JM
    J Clin Oncol; 2006 Jun; 24(16):2520-6. PubMed ID: 16735704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.
    Sasse S; Goergen H; Plütschow A; Böll B; Eichenauer DA; Fuchs M; Behringer K; Zijlstra JM; Greil R; Markova J; Topp MS; Meissner J; Neubauer A; Baues C; Engert A; Borchmann P; von Tresckow B
    J Clin Oncol; 2018 Sep; 36(25):2603-2611. PubMed ID: 29989855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adolescents with acute lymphoblastic leukemia treated at pediatric versus adult hospitals.
    Pole JD; Alibhai SM; Ethier MC; Teuffel O; Portwine C; Zelcer S; Johnston DL; Silva M; Alexander S; Brandwein JM; Sung L
    Ann Oncol; 2013 Mar; 24(3):801-6. PubMed ID: 23108950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hodgkin lymphoma in children, adolescents and young adults - a comparative study of clinical presentation and treatment outcome.
    Englund A; Glimelius I; Rostgaard K; Smedby KE; Eloranta S; Molin D; Kuusk T; Brown PN; Kamper P; Hjalgrim H; Ljungman G; Hjalgrim LL
    Acta Oncol; 2018 Feb; 57(2):276-282. PubMed ID: 28760045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABVD or BEACOPP
    Fermé C; Thomas J; Brice P; Casasnovas O; Vranovsky A; Bologna S; Lugtenburg PJ; Bouabdallah R; Carde P; Sebban C; Eghbali H; Salles G; van Imhoff GW; Thyss A; Noordijk EM; Reman O; Lybeert MLM; Janvier M; Spina M; Audhuy B; Raemaekers JMM; Delarue R; Anglaret B; de Weerdt O; Marjanovic Z; Tersteeg RJHA; de Jong D; Brière J; Henry-Amar M; ;
    Eur J Cancer; 2017 Aug; 81():45-55. PubMed ID: 28601705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial cancer treatment and survival in children, adolescents, and young adults with Hodgkin lymphoma: A population-based study.
    Kahn JM; Maguire FB; Li Q; Abrahão R; Flerlage JE; Alvarez E; Keegan THM
    Cancer; 2021 Dec; 127(24):4613-4619. PubMed ID: 34494662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom.
    Bröckelmann PJ; McMullen S; Wilson JB; Mueller K; Goring S; Stamatoullas A; Zagadailov E; Gautam A; Huebner D; Dalal M; Illidge T
    Br J Haematol; 2019 Jan; 184(2):202-214. PubMed ID: 30239982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.